Articoli correlati a CARDIOMETABOLIC INDICATORS AS PREDICTORS OF EARLY VASCULAR...

CARDIOMETABOLIC INDICATORS AS PREDICTORS OF EARLY VASCULAR AGING: In Patients With Non-alcoholic Fatty Liver Disease And Subclinical Hypothyroidism - Brossura

 
9786202528726: CARDIOMETABOLIC INDICATORS AS PREDICTORS OF EARLY VASCULAR AGING: In Patients With Non-alcoholic Fatty Liver Disease And Subclinical Hypothyroidism

Sinossi

In recent years, the concept of “cardiometabolic risk” is increasingly used in clinical practice. One of the most common diseases is non-alcoholic fatty liver disease (NAFLD) - a chronic liver disease that is considered as a component of some diseases associated with insulin resistance. The development of NAFLD on the background of comorbid pathology is closely associated with an increase in the degree of cardiometabolic risk, which can determine the prognosis and life expectancy of patients.The monograph presents the results of our own studies that demonstrated the involvement of “new” markers - C-reactive protein, tumor necrosis factor-α, endothelial dysfunction indicators such as: circulating desquamated endothelial cells, vascular endothelial growth factor and telomere length in the formation of cardiometabolic changes in patients with NAFLD on the background of subclinical hypothyroidism, which can lead to early vascular aging. The data obtained expands our understanding of cardiometabolic risk formation mechanisms, to predict the course of the disease and to individualize the strategy for the prevention of cardiovascular events in a comorbid patient.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

EUR 9,70 per la spedizione da Germania a Italia

Destinazione, tempi e costi

Risultati della ricerca per CARDIOMETABOLIC INDICATORS AS PREDICTORS OF EARLY VASCULAR...

Immagini fornite dal venditore

Olena Kolesnikova
ISBN 10: 6202528729 ISBN 13: 9786202528726
Nuovo Brossura

Da: moluna, Greven, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. Codice articolo 385946548

Contatta il venditore

Compra nuovo

EUR 24,56
Convertire valuta
Spese di spedizione: EUR 9,70
Da: Germania a: Italia
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Olena Kolesnikova
ISBN 10: 6202528729 ISBN 13: 9786202528726
Nuovo Taschenbuch
Print on Demand

Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In recent years, the concept of 'cardiometabolic risk' is increasingly used in clinical practice. One of the most common diseases is non-alcoholic fatty liver disease (NAFLD) - a chronic liver disease that is considered as a component of some diseases associated with insulin resistance. The development of NAFLD on the background of comorbid pathology is closely associated with an increase in the degree of cardiometabolic risk, which can determine the prognosis and life expectancy of patients.The monograph presents the results of our own studies that demonstrated the involvement of 'new' markers - C-reactive protein, tumor necrosis factor- , endothelial dysfunction indicators such as: circulating desquamated endothelial cells, vascular endothelial growth factor and telomere length in the formation of cardiometabolic changes in patients with NAFLD on the background of subclinical hypothyroidism, which can lead to early vascular aging. The data obtained expands our understanding of cardiometabolic risk formation mechanisms, to predict the course of the disease and to individualize the strategy for the prevention of cardiovascular events in a comorbid patient. 80 pp. Englisch. Codice articolo 9786202528726

Contatta il venditore

Compra nuovo

EUR 26,90
Convertire valuta
Spese di spedizione: EUR 11,00
Da: Germania a: Italia
Destinazione, tempi e costi

Quantità: 2 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Olena Kolesnikova
ISBN 10: 6202528729 ISBN 13: 9786202528726
Nuovo Taschenbuch

Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. Neuware -In recent years, the concept of ¿cardiometabolic risk¿ is increasingly used in clinical practice. One of the most common diseases is non-alcoholic fatty liver disease (NAFLD) - a chronic liver disease that is considered as a component of some diseases associated with insulin resistance. The development of NAFLD on the background of comorbid pathology is closely associated with an increase in the degree of cardiometabolic risk, which can determine the prognosis and life expectancy of patients.The monograph presents the results of our own studies that demonstrated the involvement of ¿new¿ markers - C-reactive protein, tumor necrosis factor-¿, endothelial dysfunction indicators such as: circulating desquamated endothelial cells, vascular endothelial growth factor and telomere length in the formation of cardiometabolic changes in patients with NAFLD on the background of subclinical hypothyroidism, which can lead to early vascular aging. The data obtained expands our understanding of cardiometabolic risk formation mechanisms, to predict the course of the disease and to individualize the strategy for the prevention of cardiovascular events in a comorbid patient.Books on Demand GmbH, Überseering 33, 22297 Hamburg 80 pp. Englisch. Codice articolo 9786202528726

Contatta il venditore

Compra nuovo

EUR 26,90
Convertire valuta
Spese di spedizione: EUR 15,00
Da: Germania a: Italia
Destinazione, tempi e costi

Quantità: 2 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Olena Kolesnikova
ISBN 10: 6202528729 ISBN 13: 9786202528726
Nuovo Taschenbuch
Print on Demand

Da: AHA-BUCH GmbH, Einbeck, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In recent years, the concept of 'cardiometabolic risk' is increasingly used in clinical practice. One of the most common diseases is non-alcoholic fatty liver disease (NAFLD) - a chronic liver disease that is considered as a component of some diseases associated with insulin resistance. The development of NAFLD on the background of comorbid pathology is closely associated with an increase in the degree of cardiometabolic risk, which can determine the prognosis and life expectancy of patients.The monograph presents the results of our own studies that demonstrated the involvement of 'new' markers - C-reactive protein, tumor necrosis factor- , endothelial dysfunction indicators such as: circulating desquamated endothelial cells, vascular endothelial growth factor and telomere length in the formation of cardiometabolic changes in patients with NAFLD on the background of subclinical hypothyroidism, which can lead to early vascular aging. The data obtained expands our understanding of cardiometabolic risk formation mechanisms, to predict the course of the disease and to individualize the strategy for the prevention of cardiovascular events in a comorbid patient. Codice articolo 9786202528726

Contatta il venditore

Compra nuovo

EUR 28,89
Convertire valuta
Spese di spedizione: EUR 14,99
Da: Germania a: Italia
Destinazione, tempi e costi

Quantità: 1 disponibili

Aggiungi al carrello